CellSource Co Ltd
TSE:4880
CellSource Co Ltd
Net Income (Common)
CellSource Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CellSource Co Ltd
TSE:4880
|
Net Income (Common)
¥923.1m
|
CAGR 3-Years
50%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Carna Biosciences Inc
TSE:4572
|
Net Income (Common)
-¥1.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-15%
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Net Income (Common)
¥5.3B
|
CAGR 3-Years
50%
|
CAGR 5-Years
29%
|
CAGR 10-Years
14%
|
|
Medinet Co Ltd
TSE:2370
|
Net Income (Common)
-¥1.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-11%
|
|
Linical Co Ltd
TSE:2183
|
Net Income (Common)
¥680.4m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
4%
|
|
WDB coco Co Ltd
TSE:7079
|
Net Income (Common)
¥743.6m
|
CAGR 3-Years
34%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
See Also
What is CellSource Co Ltd's Net Income (Common)?
Net Income (Common)
923.1m
JPY
Based on the financial report for Oct 31, 2023, CellSource Co Ltd's Net Income (Common) amounts to 923.1m JPY.
What is CellSource Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
37%
Over the last year, the Net Income (Common) growth was -9%. The average annual Net Income (Common) growth rates for CellSource Co Ltd have been 50% over the past three years , 37% over the past five years .